Delivery Order SPE2DB22D1202-SPE2DB25FUYR9
Award Date 4/24/25
Potential Completion Date 4/25/25
Potential Value $5.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a competitive delivery order valued at $2,872.80 by the Department of Defense Medical Supply Chain on July 30, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. The contract is structured as a firm fixed price delivery order with an ultimate completion date of July 31, 2025, and carries no set-aside designation. This award is issued under AmerisourceBergen's broader Indefinite...
- AmerisourceBergen Drug Corp received a $1,615.95 delivery order from the Defense Logistics Agency's Medical Supply Chain on August 19, 2025, for Ondansetron ODT 8 mg tablets (30-count packages). This is a firm fixed-price, non-set-aside contract with a completion date of August 20, 2025, and represents a child order under the company's larger contract vehicle with DLA. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania. This delivery order falls under...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $5,636.06 for Ondansetron ODT 8 mg tablets (30-count supply) on July 29, 2025, with completion expected by July 30, 2025. This firm fixed-price, competitively awarded contract (no set-aside used) represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is located at the...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $26,868.47 by the Defense Logistics Agency (DLA) on July 14, 2025, for the supply of Ondansetron HCL 4 mg tablets in quantities of 30. The contract carries a firm fixed price structure with no set-aside designation, indicating competitive award status. Performance is based in Conshohocken, Pennsylvania, with an ultimate completion date of July 15, 2025. This delivery order represents a child contract issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $42,013.50 for Ondansetron Orally Disintegrating Tablets 8mg (30-count supply) on August 21, 2025, with completion targeted for September 18, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award to the vendor. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 27, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $1,795.50, represents a competitively awarded contract with no set-aside designation and is scheduled for completion by August 28, 2025. The award was executed under AmerisourceBergen's...
- AmerisourceBergen Drug Corp was awarded a delivery order on July 30, 2025, by the Defense Logistics Agency's Medical Supply Chain to supply Ondansetron ODT 8 mg tablets in a 30-count quantity. This is a non-set-aside, competitively awarded firm fixed price delivery order with a ceiling value of $1,438.73 and an ultimate completion date of July 31, 2025. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $19,039.16 by the Defense Logistics Agency's Medical Supply Chain on August 19, 2025, for the supply of Ondansetron Orally Disintegrating Tablet 8 mg in quantities of 30 tablets. This firm fixed-price delivery order, which is not set-aside, represents a non-competitive award under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp was awarded a delivery order on September 18, 2025, valued at $5,824.12 for the supply of Ondansetron ODT 8 mg tablets in quantities of 30s under a firm fixed price contract. This is a non-set-aside award issued by the Defense Logistics Agency's Medical Supply Chain, with an ultimate completion date of September 19, 2025. The work will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $47,359.92 for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This firm fixed-price contract was awarded on September 26, 2025, with an ultimate completion date of September 29, 2025, and is funded through the Defense Logistics Agency's Medical Supply Chain, which procures pharmaceuticals and medical supplies for...